Shafqat Ahmad, Germán D Carrasquilla, Taro Langner, Uwe Menzel, Nouman Ahmad, Sergi Sayols-Baixeras, Koen F Dekkers, Beatrice Kennedy, Filip Malmberg, Ulf Hammar, María J Romero-Lado, Jenny C Censin, Diem Nguyen, Andrés Martínez Mora, Tuomas O Kilpeläinen, Lars Lind, Jan W Eriksson, Robin Strand, Joel Kullberg, Håkan Ahlström, Tove Fall
{"title":"Impact of genetic variants linked to liver fat and liver volume on MRI-mapped body composition.","authors":"Shafqat Ahmad, Germán D Carrasquilla, Taro Langner, Uwe Menzel, Nouman Ahmad, Sergi Sayols-Baixeras, Koen F Dekkers, Beatrice Kennedy, Filip Malmberg, Ulf Hammar, María J Romero-Lado, Jenny C Censin, Diem Nguyen, Andrés Martínez Mora, Tuomas O Kilpeläinen, Lars Lind, Jan W Eriksson, Robin Strand, Joel Kullberg, Håkan Ahlström, Tove Fall","doi":"10.1016/j.jhepr.2025.101468","DOIUrl":null,"url":null,"abstract":"<p><strong>Background & aims: </strong>A quarter of the world population is estimated to have metabolic dysfunction-associated steatotic liver disease. Here, we aim to understand the impact of liver trait-associated genetic variants on fat content and tissue volume across organs and body compartments and on a large set of biomarkers.</p><p><strong>Methods: </strong>Genome-wide association analyses were performed on liver fat and liver volume estimated with magnetic resonance imaging in up to 27,243 unrelated European participants from the UK Biobank. Identified variants were assessed for associations with fat fraction and tissue volume in >2 million 'Imiomics' image elements in 22,261 individuals and with circulating biomarkers in 310,224 individuals.</p><p><strong>Results: </strong>We confirmed four liver fat and nine liver volume previously reported genetic variants (<i>p</i> values <5 × 10<sup>-8</sup>). We further found evidence suggestive of a novel liver volume locus, <i>ADH4</i>, where each additional T allele increased liver volume by 0.05 SD (SE = 0.01, <i>p</i> value = 3.3 × 10<sup>-8</sup>). The Imiomics analyses showed that liver fat-increasing variants were specifically associated with fat fraction of the liver tissue (<i>p</i> values <2.8 × 10<sup>-3</sup>) and with higher inflammation, liver and renal injury biomarkers, and lower lipid levels. Associations of liver volume variants with fat content, tissue volume, and biomarkers were more heterogeneous, for example the liver volume-increasing alleles at <i>CENPW</i> and <i>PPP1R3B</i> were associated with higher skeletal muscle volumes and were more pronounced in men, whereas the <i>GCKR</i> variant was negatively associated with lower skeletal muscle volumes in women (<i>p</i> values <2.8 × 10<sup>-3</sup>).</p><p><strong>Conclusions: </strong>Liver fat-increasing variants were mostly linked to fat fraction of the liver and were positively associated with some adverse metabolic biomarkers and negatively with lipids. In contrast, liver volume-associated variants showed a less consistent pattern across organs and biomarkers.</p><p><strong>Impact and implications: </strong>Liver fat and liver volume are common metabolic traits with a strong genetic component, yet the extent to which they exert organ-specific <i>vs.</i> systemic effects remains poorly defined. By integrating genome-wide association analyses and high-resolution neck-to-knee magnetic resonance imaging data through the Imiomics framework, this study reveals distinct genetic architectures for liver fat and liver volume, including sex-specific effects. These findings provide new insights into the biological, organ-level, tissue-specific, and systemic characteristics of steatotic liver disease and its genetic determinants. The results may inform the development of precision imaging genetic approaches, biomarker discovery, and stratified risk assessment strategies, while reinforcing the importance of incorporating sex-specific analyses in future research and clinical applications.</p>","PeriodicalId":14764,"journal":{"name":"JHEP Reports","volume":"7 9","pages":"101468"},"PeriodicalIF":7.5000,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12355076/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JHEP Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jhepr.2025.101468","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background & aims: A quarter of the world population is estimated to have metabolic dysfunction-associated steatotic liver disease. Here, we aim to understand the impact of liver trait-associated genetic variants on fat content and tissue volume across organs and body compartments and on a large set of biomarkers.
Methods: Genome-wide association analyses were performed on liver fat and liver volume estimated with magnetic resonance imaging in up to 27,243 unrelated European participants from the UK Biobank. Identified variants were assessed for associations with fat fraction and tissue volume in >2 million 'Imiomics' image elements in 22,261 individuals and with circulating biomarkers in 310,224 individuals.
Results: We confirmed four liver fat and nine liver volume previously reported genetic variants (p values <5 × 10-8). We further found evidence suggestive of a novel liver volume locus, ADH4, where each additional T allele increased liver volume by 0.05 SD (SE = 0.01, p value = 3.3 × 10-8). The Imiomics analyses showed that liver fat-increasing variants were specifically associated with fat fraction of the liver tissue (p values <2.8 × 10-3) and with higher inflammation, liver and renal injury biomarkers, and lower lipid levels. Associations of liver volume variants with fat content, tissue volume, and biomarkers were more heterogeneous, for example the liver volume-increasing alleles at CENPW and PPP1R3B were associated with higher skeletal muscle volumes and were more pronounced in men, whereas the GCKR variant was negatively associated with lower skeletal muscle volumes in women (p values <2.8 × 10-3).
Conclusions: Liver fat-increasing variants were mostly linked to fat fraction of the liver and were positively associated with some adverse metabolic biomarkers and negatively with lipids. In contrast, liver volume-associated variants showed a less consistent pattern across organs and biomarkers.
Impact and implications: Liver fat and liver volume are common metabolic traits with a strong genetic component, yet the extent to which they exert organ-specific vs. systemic effects remains poorly defined. By integrating genome-wide association analyses and high-resolution neck-to-knee magnetic resonance imaging data through the Imiomics framework, this study reveals distinct genetic architectures for liver fat and liver volume, including sex-specific effects. These findings provide new insights into the biological, organ-level, tissue-specific, and systemic characteristics of steatotic liver disease and its genetic determinants. The results may inform the development of precision imaging genetic approaches, biomarker discovery, and stratified risk assessment strategies, while reinforcing the importance of incorporating sex-specific analyses in future research and clinical applications.
期刊介绍:
JHEP Reports is an open access journal that is affiliated with the European Association for the Study of the Liver (EASL). It serves as a companion journal to the highly respected Journal of Hepatology.
The primary objective of JHEP Reports is to publish original papers and reviews that contribute to the advancement of knowledge in the field of liver diseases. The journal covers a wide range of topics, including basic, translational, and clinical research. It also focuses on global issues in hepatology, with particular emphasis on areas such as clinical trials, novel diagnostics, precision medicine and therapeutics, cancer research, cellular and molecular studies, artificial intelligence, microbiome research, epidemiology, and cutting-edge technologies.
In summary, JHEP Reports is dedicated to promoting scientific discoveries and innovations in liver diseases through the publication of high-quality research papers and reviews covering various aspects of hepatology.